Saura Douglas, PA
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $538 of the $603 with a category attached, or 89.2%. It is spread thinly across 10 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $286, 2.4 times the $118 reported in 2021. That places this record below the midpoint for surgical clinicians in OK, where the typical reported total is $539.
Across 15 payments — averaging $40.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$122
- Novo Nordisk$116
- Stryker$85
- Astellas Pharma US Inc$65
- Vertex$64
- Ferring Pharmaceuticals Inc.$49
- plus $102 from 4 others
What the payments were for
- Food & beverage$53889%
- Education$6511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 1 | $122 |
| Novo Nordisk | 1 | $116 |
| Stryker | 3 | $85 |
| Astellas Pharma US Inc | 1 | $65 |
| Vertex | 3 | $64 |
| Ferring Pharmaceuticals Inc. | 2 | $49 |
| Si-bone, Inc. | 1 | $35 |
| Providence Medical Technology, Inc. | 1 | $34 |
| Johnson & Johnson | 1 | $17 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$603 in reported general payments places this provider in the 50th percentile of 94 surgical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 19 | $149 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $143 |
| Dexamethasone | 30 | $141 |
| Hydroxyzine Pamoate | 17 | $104 |
| Diazepam | 28 | $34 |
| Tramadol Hcl | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other surgical in Tulsa
- Anne EdmondsTulsa$15K
- Isaac EdmondsTulsa$7K
- Camryn CorwinTulsa$5K
- Bryce WrightTulsa$4K
- Jamie TeeterTulsa$3K
- Shawna LiszewskiTulsa$3K
- Laura JuarezTulsa$3K
- Kristi KrebsTulsa$2K
- Crista HobbsTulsa$2K
- Jarret KellerTulsa$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.